Neogen Corp (NEOG) 42.94 $NEOG
Nasdaq stocks posting largest percentage increases
AP - Thu Jul 24, 5:23PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
Neogen comments on SenesTech
PR Newswire - Thu Jul 24, 7:45AM CDT
Neogen Corporation (Nasdaq: NEOG) advised market analysts today that future forecasts of its potential revenue from new rodenticide research are premature. In its regular quarterly conference call to investors and analysts on July 22, 2014, Neogen's CEO commented about several new developments when questioned by analysts regarding this research.
Upgrade Alert for Neogen (NEOG)
Comtex SmarTrend(R) - Thu Jul 24, 7:03AM CDT
Neogen (NASDAQ:NEOG) was upgraded from Equal Weight to Overweight at Stephens today. The stock closed yesterday at $42.99 on volume of 532,000 shares, above average daily volume of 166,000. Neogen share prices have moved between a 52-week high of $70.96 and a 52-week low of $35.41 and closed yesterday at 21% above that low price at $42.99 per share. The 200-day and 50-day moving averages have moved 0.07% lower and 0.33% higher over the past week, respectively.
Global Rodenticides Market 2014-2019 - Type (Anticoagulants, Non-Anticoagulants) & End User (Agricultural Field, Warehouses, Pest Control Companies, Urban Centers) Analysis
M2 - Thu Jul 24, 4:28AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wnbvr3/rodenticides) has announced the addition of the "Rodenticides Market by Type, by End User & by Geography - Global Trends & Forecasts to 2019" report to their offering. The market for rodenticides is projected to exceed $900 million by 2019 The rodenticides market size is projected to increase due to the demand for food grains and rising farmers concerns over food wastage due to rodents. Rodenticides are also used in integrated pest management programs. The emerging markets with increasing demand for rodenticides are estimated to generate potential opportunities in the market. Pest control companies were the largest end users of rodenticides in 2013. The key players in the rodenticides market prefer new product launches as a strategy to broaden their product portfolio and garner a larger share in the market. The rodenticides market was sub-segmented into anticoagulants and non-anticoagulants. Both, the anticoagulants and non-anticoagulants markets were segmented based on their respective types and geography. To maintain a competitive edge in the rodenticides market, the key players invest heavily in the development of new bait formulations. The key players of the rodenticides market were observed to prefer new product launches as the strategy to garner a larger share in the market. The key companies have also entered into agreements and collaborations to market new products. The report provides a complete analysis of key companies and a chronology of developments with respect to new products and their applications. It also analyzes the market dynamics, winning imperatives, and issues faced by the leading players. The report provides a qualitative analysis of leading players in the market. It also enumerates the development strategies preferred by the leading market players. The market dynamics in terms of market drivers, restraints, opportunities, and challenges are discussed in detail in the report. The key players such as Syngenta AG (Switzerland), BASF SE (Germany), and Bayer CropScience (Germany) have been profiled in this report. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Premium Insights 4 Industry Analysis 5 Market Overview 6 Market Analysis 7 Rodenticides Market, By Type 8 Rodenticides Market, By End User 9 Rodenticides Market, By Geography 10 Regulations on Rodenticides 11 Competitive Landscape 12 Company Profiles - BASF SE - Bayer Cropscience Ag - Impex Europa S.L. - J.T. Eaton & Co., Inc. - Liphatech, Inc. - Neogen Corporation - Pelgar International - Senestech, Inc. - Syngenta Sa - UPL Limited For more information visit http://www.researchandmarkets.com/research/wn...denticides
Decoding 4 Stocks' Big Earnings Moves
Todd Campbell, The Motley Fool - Motley Fool - Wed Jul 23, 1:05PM CDT
Earnings season is picking up and results are driving big share price pop and drops in companies that are beating or missing on forecasts. Today, ConMed Corp , Quidel Corp . , Neogen , and Vascular Solutions are among health care's biggest...
Neogen Q4 Earnings Lag Estimates but Up Y/Y on Higher Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 23, 11:00AM CDT
For fiscal 2014, Neogen Corp. (NEOG) reported adjusted earnings per share of 76 cents, up 1.3% from 75 cents in fiscal 2013 but down from the Zacks Consensus Estimate of 77 cents.
Neogen's 2014 revenues and net income sets new all-time record
M2 - Wed Jul 23, 7:27AM CDT
Animal safety company Neogen (NasdaqGS:NEOG) on Tuesday declared net income of USD28.158m for its 2014 fiscal year that ended 31 May.
Why Neogen (NEOG) Stock Slumped Today
at The Street - Tue Jul 22, 3:08PM CDT
Neogen (NEOG) stock was down after reporting earnings and revenue for the 2014 fourth quarter that didn't meet analysts' expectations.
Neogen reports 19% increase in annual revenues
PR Newswire - Tue Jul 22, 7:45AM CDT
Neogen Corporation (NASDAQ: NEOG) announced today that revenues for its 2014 fiscal year, which ended May 31, increased 19% from the previous year to $247,405,000. Fiscal year net income was $28,158,000, compared to the prior year's $27,190,000. Adjusted for a 3-for-2 stock split effective Oct. 30, 2013, earnings per share in the current year were $0.76, compared to $0.75 a year ago. Both revenues and net income for the 2014 fiscal year established new all-time highs for the 32-year-old company.
Neogen announces planned departure of COO Stephen Snyder
M2 - Mon Jul 21, 7:04AM CDT
Animal healthcare company Neogen (NasdaqGS:NEOG) revealed on Friday the resignation of Stephen Snyder as its chief operating officer and president, with effect from 31 July 2014.
Neogen COO resigns
PR Newswire - Fri Jul 18, 3:30PM CDT
Neogen Corporation (Nasdaq: NEOG) announced today that Stephen Snyder, Neogen's chief operating officer and president, has resigned, effective July 31, 2014. The company said he will work as a consultant going forward on special projects. His resignation is for personal matters.
Shares of NEOG Down 15.0% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Thu Jul 17, 9:24AM CDT
SmarTrend identified a Downtrend for Neogen (NASDAQ:NEOG) on October 31st, 2013 at $46.59. In approximately 9 months, Neogen has returned 15.00% as of today's recent price of $39.60.
Veterinary Diagnostics Market 2014-2018 - Clinical Chemistry, Hematology Analyzers, Molecular Diagnostics, Immunodiagnostics, Diagnostics Imaging
M2 - Tue Jul 08, 4:09AM CDT
Research and Markets (http://www.researchandmarkets.com/research/pjx2qr/veterinary) has announced the addition of the "Veterinary Diagnostics Market 2014-2018 - Clinical Chemistry, Hematology Analyzers, Molecular Diagnostics, Immunodiagnostics, Diagnostics Imaging" report to their offering. The global veterinary diagnostics market is expected to grow at a healthy CAGR and is estimated to be worth $4.200 billion by 2018 The market is mainly driven by the increasing incidences of disease outbreaks, increasing companion animal market backed by the rise in the adoption of pets, increase in the disposable incomes, and the increasing incidences of zoonotic diseases. However, economic downturn and increasing adoption of vegetarian food inhibits the growth of the market to a certain extent. The global market is segmented by product, type of animal, end user, and geography. The veterinary diagnostics market is segmented, by products, broadly into clinical chemistry, hematology analyzers, molecular diagnostics, and immunodiagnostics. The animal market is segmented into companion animal and food-producing animal. The companion animal market covers dogs, cats and horses. Food-producing animal market includes into poultry, cattle, swine, and others (fish, sheep, and goat). The market is further analyzed by end users. The report covers details about various end users of veterinary diagnostics in reference laboratories, hospitals and clinics, universities/research institutes, and point-of-care. By 2018, North America will continue to drive and dominate the veterinary diagnostics market. However, the market share of this region will decrease slightly during 2013 to 2018, primarily due to the increase in demand for veterinary diagnostic tests in the Asia-Pacific and Latin American countries. Majority of the growth in the Asia-pacific region is primarily driven by the increasing demand of diagnostic tests in the animal health industry in China and India. The growth in the Asia-Pacific and Latin American regions can be attributed to the increased disposable incomes leading to growth in the per capita animal health expenditure in these regions. Scope Products - Clinical Chemistry - Hematology Analyzers - Molecular Diagnostics - Immunodiagnostics - Diagnostics Imaging Animals - Companion - Food-producing - Dog - Livestock - Poultry - Swine Key Topics Covered: 1 Introduction 2 Executive Summary 3 Premium Insights 4 Market Overview 5 Veterinary Diagnostics Market, By Product 6 Global Veterinary Diagnostics Market, By Type Of Animal 7 Veterinary Diagnostics Market, By End User 8 Geographic Analysis 9 Competitive Landscape 10 Company Profiles - Abaxis, Inc. - Heska Corporation - Idexx Laboratories, Inc. - Idvet - Mindray Medical International Ltd. - Neogen Corporation - Thermo Fisher Scientific Inc. - Vca Antech, Inc. - Virbac Sa - Zoetis, Inc. For more information visit http://www.researchandmarkets.com/research/pjx2qr/veterinary
16.8% Return Seen to Date on SmarTrend Neogen Call (NEOG)
Comtex SmarTrend(R) - Wed Jun 25, 9:24AM CDT
SmarTrend identified a Downtrend for Neogen (NASDAQ:NEOG) on October 31st, 2013 at $46.59. In approximately 8 months, Neogen has returned 16.78% as of today's recent price of $38.77.
Global Food Diagnostics Systems (Hybridization Chromatography, Spectrometry, Biosensors, Immunoassay & Testing kits) Market 2014-2018
M2 - Wed Jun 25, 4:31AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4t4xfp/food_diagnostics) has announced the addition of the "Food Diagnostics Systems Market by Type, Consumables Market & By Geography - Global Trends & Forecast To 2018" report to their offering. The food diagnostics market was sub-segmented into diagnostic systems and consumables. Both, the diagnostic systems and consumables markets were segmented based on their respective types and geography. The food diagnostic systems include hybridization-based systems such as PCR, gene amplifiers, microarrays, and sequencers; chromatography-based systems such as gas chromatography (GC), liquid chromatography (LC), and high-pressure liquid chromatography (HPLC); spectrometry-based systems such as mass spectrometry (MS); biosensors; immunoassay-based systems such as ELISA; and test kits. Food diagnostic systems are used to analyze food samples to determine their nutritional content, quality, and to detect the presence of contaminants in the samples. The food diagnostic consumables include reagents essential for performing the tests, disinfectants, and test accessories such as syringes, pipettes, among others. The North American market was estimated as the largest food diagnostic systems market in 2013. The Asia-Pacific market is estimated to grow at the highest CAGR with emerging markets in the region and increasing demand for food safety and quality. The European market is driven by the stringent food safety and disease prevention regulations. The reagents market was estimated as the largest food diagnostic consumables market in 2013. The markets for disinfectants and reagents are estimated to grow with the increasing demand for food testing. Scope of the Report Food Diagnostic Systems On the basis of type: - Hybridization-based - Chromatography-based - Spectrometry-based - Biosensors - Immunoassay-based - Testing kits - Others (colony counters, microtome, and spreaders, among others) Food Diagnostic Consumables On the basis of type: - Reagents - Disinfectants - Test accessories (pipettes, micropipettes, and syringes, among others) - Others (gloves and disposable bags, among others) Key Topics Covered: 1 Introduction 2 Executive Summary 3 Premium Insights 4 Industry Analysis 5 Market Overview 6 Market Analysis 7 Food Diagnostics Systems Market, By Type 8 Food Diagnostics Systems Market, By Geography 9 Food Diagnostic Consumables Market, By Type 10 Food Diagnostic Consumables Market, By Geography 11 Regulations For Food Safety & Disease Prevention 12 Competitive Landscape 13 Company Profiles - 3M Company - Bioconrtol Systems, Inc. - Biom?rieux Sa - Danaher Corporation - E. I. Du Pont De Nemours And Company - Foss A/S - Merck Kgaa - Neogen Corporation - Perkinelmer Inc. - Thermo Fisher Scientific Inc. For more information visit http://www.researchandmarkets.com/research/4t...iagnostics
Neogen Finds Partner for Rodent Control Product - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jun 17, 5:20PM CDT
SenesTech believes Neogen (NEOG) is the right partner for the project due to its size and market presence.
Neogen Shares Down 16.3% Since SmarTrend's Sell Call (NEOG)
Comtex SmarTrend(R) - Tue Jun 17, 5:06PM CDT
SmarTrend identified a Downtrend for Neogen (NASDAQ:NEOG) on October 31st, 2013 at $46.59. In approximately 8 months, Neogen has returned 16.29% as of today's recent price of $39.00.
Nasdaq stocks posting largest percentage increases
AP - Thu Jul 24, 5:23PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
Neogen comments on SenesTech
PR Newswire - Thu Jul 24, 7:45AM CDT
Neogen Corporation (Nasdaq: NEOG) advised market analysts today that future forecasts of its potential revenue from new rodenticide research are premature. In its regular quarterly conference call to investors and analysts on July 22, 2014, Neogen's CEO commented about several new developments when questioned by analysts regarding this research.
Upgrade Alert for Neogen (NEOG)
Comtex SmarTrend(R) - Thu Jul 24, 7:03AM CDT
Neogen (NASDAQ:NEOG) was upgraded from Equal Weight to Overweight at Stephens today. The stock closed yesterday at $42.99 on volume of 532,000 shares, above average daily volume of 166,000. Neogen share prices have moved between a 52-week high of $70.96 and a 52-week low of $35.41 and closed yesterday at 21% above that low price at $42.99 per share. The 200-day and 50-day moving averages have moved 0.07% lower and 0.33% higher over the past week, respectively.
Global Rodenticides Market 2014-2019 - Type (Anticoagulants, Non-Anticoagulants) & End User (Agricultural Field, Warehouses, Pest Control Companies, Urban Centers) Analysis
M2 - Thu Jul 24, 4:28AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wnbvr3/rodenticides) has announced the addition of the "Rodenticides Market by Type, by End User & by Geography - Global Trends & Forecasts to 2019" report to their offering. The market for rodenticides is projected to exceed $900 million by 2019 The rodenticides market size is projected to increase due to the demand for food grains and rising farmers concerns over food wastage due to rodents. Rodenticides are also used in integrated pest management programs. The emerging markets with increasing demand for rodenticides are estimated to generate potential opportunities in the market. Pest control companies were the largest end users of rodenticides in 2013. The key players in the rodenticides market prefer new product launches as a strategy to broaden their product portfolio and garner a larger share in the market. The rodenticides market was sub-segmented into anticoagulants and non-anticoagulants. Both, the anticoagulants and non-anticoagulants markets were segmented based on their respective types and geography. To maintain a competitive edge in the rodenticides market, the key players invest heavily in the development of new bait formulations. The key players of the rodenticides market were observed to prefer new product launches as the strategy to garner a larger share in the market. The key companies have also entered into agreements and collaborations to market new products. The report provides a complete analysis of key companies and a chronology of developments with respect to new products and their applications. It also analyzes the market dynamics, winning imperatives, and issues faced by the leading players. The report provides a qualitative analysis of leading players in the market. It also enumerates the development strategies preferred by the leading market players. The market dynamics in terms of market drivers, restraints, opportunities, and challenges are discussed in detail in the report. The key players such as Syngenta AG (Switzerland), BASF SE (Germany), and Bayer CropScience (Germany) have been profiled in this report. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Premium Insights 4 Industry Analysis 5 Market Overview 6 Market Analysis 7 Rodenticides Market, By Type 8 Rodenticides Market, By End User 9 Rodenticides Market, By Geography 10 Regulations on Rodenticides 11 Competitive Landscape 12 Company Profiles - BASF SE - Bayer Cropscience Ag - Impex Europa S.L. - J.T. Eaton & Co., Inc. - Liphatech, Inc. - Neogen Corporation - Pelgar International - Senestech, Inc. - Syngenta Sa - UPL Limited For more information visit http://www.researchandmarkets.com/research/wn...denticides
Decoding 4 Stocks' Big Earnings Moves
Todd Campbell, The Motley Fool - Motley Fool - Wed Jul 23, 1:05PM CDT
Earnings season is picking up and results are driving big share price pop and drops in companies that are beating or missing on forecasts. Today, ConMed Corp , Quidel Corp . , Neogen , and Vascular Solutions are among health care's biggest...
Neogen Q4 Earnings Lag Estimates but Up Y/Y on Higher Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 23, 11:00AM CDT
For fiscal 2014, Neogen Corp. (NEOG) reported adjusted earnings per share of 76 cents, up 1.3% from 75 cents in fiscal 2013 but down from the Zacks Consensus Estimate of 77 cents.
Neogen's 2014 revenues and net income sets new all-time record
M2 - Wed Jul 23, 7:27AM CDT
Animal safety company Neogen (NasdaqGS:NEOG) on Tuesday declared net income of USD28.158m for its 2014 fiscal year that ended 31 May.
Why Neogen (NEOG) Stock Slumped Today
at The Street - Tue Jul 22, 3:08PM CDT
Neogen (NEOG) stock was down after reporting earnings and revenue for the 2014 fourth quarter that didn't meet analysts' expectations.
Neogen reports 19% increase in annual revenues
PR Newswire - Tue Jul 22, 7:45AM CDT
Neogen Corporation (NASDAQ: NEOG) announced today that revenues for its 2014 fiscal year, which ended May 31, increased 19% from the previous year to $247,405,000. Fiscal year net income was $28,158,000, compared to the prior year's $27,190,000. Adjusted for a 3-for-2 stock split effective Oct. 30, 2013, earnings per share in the current year were $0.76, compared to $0.75 a year ago. Both revenues and net income for the 2014 fiscal year established new all-time highs for the 32-year-old company.
Neogen announces planned departure of COO Stephen Snyder
M2 - Mon Jul 21, 7:04AM CDT
Animal healthcare company Neogen (NasdaqGS:NEOG) revealed on Friday the resignation of Stephen Snyder as its chief operating officer and president, with effect from 31 July 2014.
Neogen COO resigns
PR Newswire - Fri Jul 18, 3:30PM CDT
Neogen Corporation (Nasdaq: NEOG) announced today that Stephen Snyder, Neogen's chief operating officer and president, has resigned, effective July 31, 2014. The company said he will work as a consultant going forward on special projects. His resignation is for personal matters.
Shares of NEOG Down 15.0% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Thu Jul 17, 9:24AM CDT
SmarTrend identified a Downtrend for Neogen (NASDAQ:NEOG) on October 31st, 2013 at $46.59. In approximately 9 months, Neogen has returned 15.00% as of today's recent price of $39.60.
Veterinary Diagnostics Market 2014-2018 - Clinical Chemistry, Hematology Analyzers, Molecular Diagnostics, Immunodiagnostics, Diagnostics Imaging
M2 - Tue Jul 08, 4:09AM CDT
Research and Markets (http://www.researchandmarkets.com/research/pjx2qr/veterinary) has announced the addition of the "Veterinary Diagnostics Market 2014-2018 - Clinical Chemistry, Hematology Analyzers, Molecular Diagnostics, Immunodiagnostics, Diagnostics Imaging" report to their offering. The global veterinary diagnostics market is expected to grow at a healthy CAGR and is estimated to be worth $4.200 billion by 2018 The market is mainly driven by the increasing incidences of disease outbreaks, increasing companion animal market backed by the rise in the adoption of pets, increase in the disposable incomes, and the increasing incidences of zoonotic diseases. However, economic downturn and increasing adoption of vegetarian food inhibits the growth of the market to a certain extent. The global market is segmented by product, type of animal, end user, and geography. The veterinary diagnostics market is segmented, by products, broadly into clinical chemistry, hematology analyzers, molecular diagnostics, and immunodiagnostics. The animal market is segmented into companion animal and food-producing animal. The companion animal market covers dogs, cats and horses. Food-producing animal market includes into poultry, cattle, swine, and others (fish, sheep, and goat). The market is further analyzed by end users. The report covers details about various end users of veterinary diagnostics in reference laboratories, hospitals and clinics, universities/research institutes, and point-of-care. By 2018, North America will continue to drive and dominate the veterinary diagnostics market. However, the market share of this region will decrease slightly during 2013 to 2018, primarily due to the increase in demand for veterinary diagnostic tests in the Asia-Pacific and Latin American countries. Majority of the growth in the Asia-pacific region is primarily driven by the increasing demand of diagnostic tests in the animal health industry in China and India. The growth in the Asia-Pacific and Latin American regions can be attributed to the increased disposable incomes leading to growth in the per capita animal health expenditure in these regions. Scope Products - Clinical Chemistry - Hematology Analyzers - Molecular Diagnostics - Immunodiagnostics - Diagnostics Imaging Animals - Companion - Food-producing - Dog - Livestock - Poultry - Swine Key Topics Covered: 1 Introduction 2 Executive Summary 3 Premium Insights 4 Market Overview 5 Veterinary Diagnostics Market, By Product 6 Global Veterinary Diagnostics Market, By Type Of Animal 7 Veterinary Diagnostics Market, By End User 8 Geographic Analysis 9 Competitive Landscape 10 Company Profiles - Abaxis, Inc. - Heska Corporation - Idexx Laboratories, Inc. - Idvet - Mindray Medical International Ltd. - Neogen Corporation - Thermo Fisher Scientific Inc. - Vca Antech, Inc. - Virbac Sa - Zoetis, Inc. For more information visit http://www.researchandmarkets.com/research/pjx2qr/veterinary
16.8% Return Seen to Date on SmarTrend Neogen Call (NEOG)
Comtex SmarTrend(R) - Wed Jun 25, 9:24AM CDT
SmarTrend identified a Downtrend for Neogen (NASDAQ:NEOG) on October 31st, 2013 at $46.59. In approximately 8 months, Neogen has returned 16.78% as of today's recent price of $38.77.
Global Food Diagnostics Systems (Hybridization Chromatography, Spectrometry, Biosensors, Immunoassay & Testing kits) Market 2014-2018
M2 - Wed Jun 25, 4:31AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4t4xfp/food_diagnostics) has announced the addition of the "Food Diagnostics Systems Market by Type, Consumables Market & By Geography - Global Trends & Forecast To 2018" report to their offering. The food diagnostics market was sub-segmented into diagnostic systems and consumables. Both, the diagnostic systems and consumables markets were segmented based on their respective types and geography. The food diagnostic systems include hybridization-based systems such as PCR, gene amplifiers, microarrays, and sequencers; chromatography-based systems such as gas chromatography (GC), liquid chromatography (LC), and high-pressure liquid chromatography (HPLC); spectrometry-based systems such as mass spectrometry (MS); biosensors; immunoassay-based systems such as ELISA; and test kits. Food diagnostic systems are used to analyze food samples to determine their nutritional content, quality, and to detect the presence of contaminants in the samples. The food diagnostic consumables include reagents essential for performing the tests, disinfectants, and test accessories such as syringes, pipettes, among others. The North American market was estimated as the largest food diagnostic systems market in 2013. The Asia-Pacific market is estimated to grow at the highest CAGR with emerging markets in the region and increasing demand for food safety and quality. The European market is driven by the stringent food safety and disease prevention regulations. The reagents market was estimated as the largest food diagnostic consumables market in 2013. The markets for disinfectants and reagents are estimated to grow with the increasing demand for food testing. Scope of the Report Food Diagnostic Systems On the basis of type: - Hybridization-based - Chromatography-based - Spectrometry-based - Biosensors - Immunoassay-based - Testing kits - Others (colony counters, microtome, and spreaders, among others) Food Diagnostic Consumables On the basis of type: - Reagents - Disinfectants - Test accessories (pipettes, micropipettes, and syringes, among others) - Others (gloves and disposable bags, among others) Key Topics Covered: 1 Introduction 2 Executive Summary 3 Premium Insights 4 Industry Analysis 5 Market Overview 6 Market Analysis 7 Food Diagnostics Systems Market, By Type 8 Food Diagnostics Systems Market, By Geography 9 Food Diagnostic Consumables Market, By Type 10 Food Diagnostic Consumables Market, By Geography 11 Regulations For Food Safety & Disease Prevention 12 Competitive Landscape 13 Company Profiles - 3M Company - Bioconrtol Systems, Inc. - Biom?rieux Sa - Danaher Corporation - E. I. Du Pont De Nemours And Company - Foss A/S - Merck Kgaa - Neogen Corporation - Perkinelmer Inc. - Thermo Fisher Scientific Inc. For more information visit http://www.researchandmarkets.com/research/4t...iagnostics
Neogen Finds Partner for Rodent Control Product - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jun 17, 5:20PM CDT
SenesTech believes Neogen (NEOG) is the right partner for the project due to its size and market presence.
Neogen Shares Down 16.3% Since SmarTrend's Sell Call (NEOG)
Comtex SmarTrend(R) - Tue Jun 17, 5:06PM CDT
SmarTrend identified a Downtrend for Neogen (NASDAQ:NEOG) on October 31st, 2013 at $46.59. In approximately 8 months, Neogen has returned 16.29% as of today's recent price of $39.00.
